ProKidney (MEX:PROK) Scaled Net Operating Assets : 0.14 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ProKidney's operating assets for the quarter that ended in Jun. 2024 was MXN1,239.03 Mil. ProKidney's operating liabilities for the quarter that ended in Jun. 2024 was MXN368.69 Mil. ProKidney's Total Assets for the quarter that ended in Mar. 2024 was MXN6,435.41 Mil. Therefore, ProKidney's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.14.

ProKidney Scaled Net Operating Assets Historical Data

The historical data trend for ProKidney's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Scaled Net Operating Assets Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

0.41

0.48

0.40

0.06

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial										0.03	0.07	0.07	0.09	0.14

Competitive Comparison of ProKidney's Scaled Net Operating Assets

For the Biotechnology subindustry, ProKidney's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProKidney's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProKidney's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where ProKidney's Scaled Net Operating Assets falls into.

ProKidney Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ProKidney's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(977.751	-	421.013)	/	10098.85
=	0.06

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	7138.554	-	6160.803
=	977.751

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	495.92	-	61.277	-	13.63
=	421.013

ProKidney's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Mar. 2024 )
=	(1239.026	-	368.693)	/	6435.414
=	0.14

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	9144.718	-	7905.692
=	1239.026

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	490.924	-	103.325	-	18.906
=	368.693

ProKidney Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of ProKidney's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ProKidney Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.